92 related articles for article (PubMed ID: 3551350)
1. [Effect and side effects of a depot theophylline preparation within the scope of a clinical trial].
Wilke A; Weinecke A; Weide W; Schäfer K; Iwainsky H
Z Erkr Atmungsorgane; 1986; 167(3):245-53. PubMed ID: 3551350
[TBL] [Abstract][Full Text] [Related]
2. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
Wiesner B; Sehrt I; Iwainsky H
Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
[TBL] [Abstract][Full Text] [Related]
3. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
4. [Possibilities for optimizing therapy with theophylline preparations. III. Ventilatory effect and pharmacokinetics of "new" Pulmophyllin].
Kandt D; Sehrt I; Iwainsky H
Z Erkr Atmungsorgane; 1984; 162(1):18-25. PubMed ID: 6719956
[TBL] [Abstract][Full Text] [Related]
5. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
Arbab OA; Wiggins J; Ayres JG; Stableforth DE
Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
[TBL] [Abstract][Full Text] [Related]
6. [Tolerance and effect of short-term theophylline infusions].
Schmidt M
Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
Arens PJ
Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
[TBL] [Abstract][Full Text] [Related]
8. [Comparative subacute study of the effects and side effects of a non-depot theophylline preparation (Euspirax) and a depot preparation (Euphyllin retard)--a contribution to long-term therapy of asthma].
Eitner L; Wettengel R; Schnitker J
Prax Klin Pneumol; 1983 Jun; 37(6):236-42. PubMed ID: 6889277
[No Abstract] [Full Text] [Related]
9. [Effectiveness of proxyphylline in chronic obstructive pulmonary disease (author's transl)].
Geisler LS; Thiel H; Förster OB; Rohner HG
Dtsch Med Wochenschr; 1980 Jun; 105(25):894-7. PubMed ID: 7408664
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
11. [Relation of dose, serum concentration and side effects in intravenous aminophylline therapy].
Katz G; Kewitz G; Vozeh S; Follath F
Schweiz Med Wochenschr; 1981 Dec; 111(52):2054-6. PubMed ID: 7330656
[TBL] [Abstract][Full Text] [Related]
12. A double-blind trial of oral aminophylline (Phyllocontin Continus tablets) in airflow obstruction: preliminary communication.
Greening AP; Baillie E; Gribbin HR; Pride NB
J Int Med Res; 1979; 7 Suppl 1():47-51. PubMed ID: 374164
[TBL] [Abstract][Full Text] [Related]
13. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
Salikova VV; Nonikov VE; Belousov IuB
Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
Eichhorn J; Perré R
Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
[No Abstract] [Full Text] [Related]
15. [Possibilities for optimizing therapy with theophylline preparations. Clinical effectiveness and side effects of microcrystalline theophylline].
Wiesner B; Sehrt I; Iwainsky H
Z Erkr Atmungsorgane; 1984; 162(1):11-7. PubMed ID: 6426180
[TBL] [Abstract][Full Text] [Related]
16. [Long-term therapy with a retard theophylline preparation].
Keller A; Bömches B; Kandt D
Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018
[TBL] [Abstract][Full Text] [Related]
17. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation.
Dal Negro R; Turco P; Pomari C; Monici-Preti P
Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):401-5. PubMed ID: 3305382
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic disposition of theophylline in horses after intravenous administration.
Kowalczyk DF; Beech J; Littlejohn D
Am J Vet Res; 1984 Nov; 45(11):2272-5. PubMed ID: 6524719
[TBL] [Abstract][Full Text] [Related]
19. Sustained release oral aminophylline in patients with airflow obstruction.
Greening AP; Baillie E; Gribbin HR; Pride NB
Thorax; 1981 Apr; 36(4):303-7. PubMed ID: 7025336
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
Dettmer HH
Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
